Kevin Holden

8PUBLICATIONS
245CO-AUTHORS
Powder and particle technologyEpigenetics (incl. genome methylation and epigenomics)Programming languagesCheminformatics and quantitative structure-activity relationshipsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 17, 2025
Enhanced RNA-targeting CRISPR-Cas technology in zebrafish.

Ismael Moreno-Sánchez, Luis Hernández-Huertas, Daniel Nahón-Cano

|Aug 10, 2023
Generation of precision preclinical cancer models using regulated in vivo base editing.

Alyna Katti, Adrián Vega-Pérez, Miguel Foronda

|Nov 24, 2022
Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases.

Matthew T N Yarnall, Eleonora I Ioannidi, Cian Schmitt-Ulms

|May 19, 2022
Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro.

Leiping Zeng, Yanxia Liu, Xammy Huu Wrynla

|May 04, 2022
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.

Alice Mac Kain, Ghizlane Maarifi, Sophie-Marie Aicher

|Jan 14, 2022
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2.

Avi J Samelson, Quang Dinh Tran, Rémy Robinot

Pageof 2